BioCardia, Inc. (BCDAW) Financials

BCDAW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 3.7 million 4.4 million
June 30, 2023 6.4 million 4.8 million
March 31, 2023 7.1 million 5.2 million
Dec. 31, 2022 9.8 million 4.9 million

BCDAW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -2.4 million 251000
June 30, 2023 -3.2 million 317000
March 31, 2023 -2.6 million 278000
Dec. 31, 2022 -3.0 million 280000

BCDAW Net Income

No data available :(

BCDAW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 1.8 million - 1.4 million
June 30, 2023 4.3 million - 1.5 million
March 31, 2023 4.9 million - 1.6 million
Dec. 31, 2022 7.4 million - 1.6 million

BCDAW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 21.6 million
June 30, 2023 20.4 million
March 31, 2023 20.2 million
Dec. 31, 2022 17.7 million

BCDAW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 1.9 million 1.1 million -
June 30, 2023 2000 2.3 million 1.2 million -
March 31, 2023 10000 2.4 million 1.2 million -
Dec. 31, 2022 2000 2.2 million 924000 -

BCDAW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 357000 104000
June 30, 2023 43000 101000
March 31, 2023 64000 101000
Dec. 31, 2022 106000 11.9 million

BCDAW

Price: $0.01

52 week price:
0.01
0.01

Earnings Per Share: -3.20 USD

P/E Ratio: -0.01

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 9104

Market Capitalization: 4.4 million

Links: